Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

646 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prevention of recurrent but not spontaneous autoimmune diabetes by transplanted NOD islets adenovirally transduced with immunomodulating molecules.
Sakata M, Yasuda H, Moriyama H, Yamada K, Kotani R, Kurohara M, Okumachi Y, Kishi M, Arai T, Hara K, Hamada H, Yokono K, Nagata M. Sakata M, et al. Among authors: kishi m. Diabetes Res Clin Pract. 2008 Jun;80(3):352-9. doi: 10.1016/j.diabres.2008.01.030. Epub 2008 Apr 8. Diabetes Res Clin Pract. 2008. PMID: 18400329
Immunological aspects of 'fulminant type 1 diabetes'.
Nagata M, Moriyama H, Kotani R, Yasuda H, Kishi M, Kurohara M, Hara K, Yokono K. Nagata M, et al. Among authors: kishi m. Diabetes Res Clin Pract. 2007 Sep;77 Suppl 1:S99-103. doi: 10.1016/j.diabres.2007.01.041. Epub 2007 May 2. Diabetes Res Clin Pract. 2007. PMID: 17478003
One amino acid difference is critical for suppression of the development of experimental autoimmune diabetes (EAD) with intravenous injection of insulinB:9-23 peptide.
Okumachi Y, Moriyama H, Kameno M, Arai T, Kishi M, Kurohara M, Yamada K, Yasuda H, Hara K, Yokono K, Nagata M. Okumachi Y, et al. Among authors: kishi m. Biochem Biophys Res Commun. 2008 Sep 26;374(3):581-6. doi: 10.1016/j.bbrc.2008.07.066. Epub 2008 Jul 21. Biochem Biophys Res Commun. 2008. PMID: 18647597
Comprehensive Evaluation of Combination Therapy with Basal Insulin and Either Lixisenatide or Vildagliptin in Japanese Patients with Type 2 Diabetes: A Randomized, Open-Label, Parallel-Group, Multicenter Study.
Otowa-Suematsu N, Sakaguchi K, Nakamura T, Hara K, Kishi M, Hashimoto N, Yokota K, Yoshino H, Kuroki Y, Nishiumi T, Sou A, Komada H, Okada Y, Hirota Y, Tamori Y, Ogawa W. Otowa-Suematsu N, et al. Among authors: kishi m. Diabetes Ther. 2018 Oct;9(5):2067-2079. doi: 10.1007/s13300-018-0505-2. Epub 2018 Sep 11. Diabetes Ther. 2018. PMID: 30206903 Free PMC article.
Effects of Insulin Degludec and Insulin Glargine U300 on Day-to-Day Fasting Plasma Glucose Variability in Individuals with Type 1 Diabetes: A Multicenter, Randomized, Crossover Study (Kobe Best Basal Insulin Study 2).
Miura H, Sakaguchi K, Okada Y, Otowa-Suematsu N, Yamada T, So A, Komada H, Hirota Y, Kishi M, Takeda A, Tominaga Y, Nakamura T, Kuroki Y, Matsuda T, Iida K, Kajikawa M, Ohara T, Yokota K, Hara K, Tateya S, Tamori Y, Ogawa W. Miura H, et al. Among authors: kishi m. Diabetes Ther. 2018 Dec;9(6):2399-2406. doi: 10.1007/s13300-018-0523-0. Epub 2018 Oct 19. Diabetes Ther. 2018. PMID: 30341665 Free PMC article.
646 results